This TikTok from @silversglowup shows someone injecting Mounjaro (tirzepatide) into their arm while using wellness and weight management hashtags. The video doesn't make explicit medical claims, but let's examine what's happening here.
What does this video actually show?
The creator is injecting Mounjaro into their upper arm and framing it as part of their "wellness journey." They're using the correct hashtag #glp1agonist, which suggests they understand what type of medication this is.
The injection technique appears standard. Most people inject tirzepatide in the abdomen, thigh, or upper arm, rotating sites to prevent lipodystrophy. The arm is a perfectly valid injection site.
What's interesting is the wellness framing. Mounjaro isn't a wellness supplement or lifestyle enhancement. It's a prescription medication approved by the FDA for type 2 diabetes, with Zepbound (same active ingredient) approved specifically for weight management.
Is the arm injection technique correct?
Yes, injecting tirzepatide in the upper arm is medically appropriate. The prescribing information specifically lists the upper arm as an approved injection site alongside the abdomen and thigh.
The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) that led to Zepbound's approval didn't specify injection sites, but clinical practice supports rotating between all three areas. Some people find the arm more convenient or less sensitive than abdominal injections.
However, proper injection technique matters. You should pinch the skin, inject at a 90-degree angle, and hold for 6 seconds after injection. The video is too brief to assess whether these steps were followed correctly.
What's misleading about the wellness framing?
Calling tirzepatide part of a "wellness journey" downplays what this medication actually is. This isn't a vitamin or supplement you pick up for general health.
Tirzepatide works by activating GLP-1 and GIP receptors, slowing gastric emptying and reducing appetite. In SURMOUNT-1, participants lost an average of 20.9% of body weight on the 15mg dose over 72 weeks. That's not wellness optimization, that's significant metabolic intervention.
The side effect profile includes nausea (experienced by 20.7% of participants), vomiting, diarrhea, and potential pancreatitis. Real medications have real risks that wellness language tends to minimize.
Does the science support using tirzepatide for weight loss?
Absolutely, but only in specific populations. The SURMOUNT trials showed impressive results, with participants losing 15-22.5% of body weight depending on the dose.
The FDA approved Zepbound (tirzepatide) for weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. This isn't approved for people who want to lose 10 pounds for aesthetic reasons.
The SURMOUNT-1 trial enrolled people with an average BMI of 38. These were individuals with obesity, not people looking to optimize their wellness. The medication showed clear benefits in this population, reducing cardiovascular risk factors and improving quality of life measures.
However, we don't have long-term data beyond 72 weeks. The SURMOUNT-4 trial showed that people regained about half the weight they'd lost when they stopped the medication.
What should you know about tirzepatide?
First, this requires a prescription and medical supervision. You can't just decide to start this as part of your wellness routine.
The dosing schedule matters. Most people start at 2.5mg weekly, increasing by 2.5mg every 4 weeks up to a maximum of 15mg. The gradual increase helps minimize gastrointestinal side effects, which are common early on.
Cost is significant. Without insurance coverage, tirzepatide can cost over $1,000 monthly. Insurance coverage varies widely, and many plans don't cover it for weight management specifically.
@silversglowup gets credit for showing proper injection technique and using accurate hashtags. But framing prescription weight management medication as general wellness content misses the mark on what this drug actually represents.